GBS is now the largest specialist life science investor in Australia and New Zealand with over $400m in funds under management from seed through to expansion stage. GBS believes that life science investment requires specific expertise for consistent high level performance and the GBS founders built the business with this in mind, each element of the business reflecting commitment to this approach.

GBS invests in and adds value to unlisted high growth companies involved in innovative technologies such as:

• Human therapeutics and diagnostics
• Animal therapeutics and diagnostics
• Medical devices
• Health information technology
• Agribusiness, food and environmental technology

www.gbsventures.com.au